Stoke Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational ...
PharmiWeb

Stoke Therapeutics Appoints Clare Kahn, Ph.D., to its Board of Directors

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...
Fierce Biotech

Biogen links up with Alloy platform to boost ASO drug development

When a biopharma company known for its expertise in a specific domain turns to a collaborator to expand its capabilities in ...

Why Biogen Stock Got Mashed on Monday

Healthcare company Biogen (BIIB 2.82%) wasn't looking very healthy on the stock market on Monday. Investors traded out of its ...

Is This Biotech Stock Your Best Shot at Building a Millionaire-Making Position?

With an approved treatment in commercial stages and new drug candidates generating clinical trial results, this biotech has ...